Idaho shares in national settlement

Idaho will recover nearly $420,000 from an Indian generic drug manufacturer who admitted selling drugs of inferior strength, purity or quality in the United States, including through Idaho’s Medicaid program.

It’s part of a $350 million national settlement between the federal government, the states and the company, which also pleaded guilty to seven felony counts and will pay $150 million in criminal fines and forfeitures.

“Taxpayers expect their tax dollars to be used to pay for a legitimate service,” Idaho Attorney General Lawrence Wasden said. “This settlement reflects our resolve to address losses to the Idaho Medicaid program caused by individuals and companies.” Read more . Betsy Russell, EOB

Thoughts?